Creative Medical Technology Holdings, Inc. Common Stock vs. Repligen Corp
CELZ
Creative Medical Technology Holdings, Inc. Common Stock
$1.22 -1.61%
VS RGENRepligen Corp
$166.83 -0.39%
Creative Medical Technology Holdings, Inc. Common Stock and Repligen Corp are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| CELZ | RGEN | |
|---|---|---|
| Market Cap | $8.04 million | $9.42 billion |
| Revenue (TTM) | — | $785.10 million |
| Net Income (TTM) | — | $41.54 million |
RGEN leads on 1 of 1 size & scale factors.
Valuation
| CELZ | RGEN | |
|---|---|---|
| P/E Ratio | — | 228.53 |
| Price / Book | — | 4.46 |
| Price / Sales | — | 11.99 |
CELZ and RGEN split the valuation factors evenly.
Profitability
| CELZ | RGEN | |
|---|---|---|
| Net Margin | — | 5.29% |
| Return on Equity | — | 1.97% |
CELZ and RGEN split the profitability factors evenly.
Risk & Sentiment
| CELZ | RGEN | |
|---|---|---|
| Short Interest | 0.25% | 7.13% |
CELZ leads on 1 of 1 risk & sentiment factors.
Dig deeper: CELZ overview, CELZ financials, RGEN overview, RGEN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.